New Computational Approach to Enhance Cancer Treatment Planning

Understanding Radiation Therapy

Radiation therapy is a prevalent cancer treatment that employs high-energy electromagnetic radiation, such as gamma rays or X-rays, to target and eliminate tumor cells. Electromagnetic waves consist of energy packets known as photons, which play a crucial role in combating cancer by damaging the DNA of these cells, preventing their uncontrolled growth. Approximately half of all cancer patients undergo some form of radiation therapy during their treatment, often in conjunction with surgery or chemotherapy.

Challenges of Radiation Therapy

While radiation therapy can yield positive outcomes, it is not without considerable side effects. A significant concern is that radiation affects not only cancer cells but also healthy tissue surrounding the tumor, leading to damage to normal cells. In certain cases, this collateral damage is intentional to ensure the eradication of spreading cancer cells. However, some body areas are more radiation-sensitive, which can result in patients receiving doses that approach lifetime maximum limits.

Strategies for Reducing Radiation Therapy Side Effects

Advancements in Medical Physics

Recent research in medical physics has concentrated on minimizing the side effects associated with radiation therapy. This research has led to improved target definition, more sophisticated treatment planning systems, and enhanced control over dose distributions. One notable advancement is Intensity Modulated Radiation Therapy (IMRT), where the radiation beam is segmented into smaller beamlets, each with varying intensities. IMRT not only reduces toxicity to normal tissues but also allows for the simultaneous delivery of diverse radiation doses to different tumor areas.

The Concept of Non-uniform Fractionation

Traditionally, radiation doses are administered in uniform fractions to enable normal tissue recovery. However, IMRT introduces the concept of non-uniform fractionation, wherein clinicians can adjust the strength and location of radiation across fewer fractions during treatment. This approach can minimize treatment duration and potentially counteract tumor cell repopulation while ensuring that healthy tissue is not more adversely affected compared to conventional methods.

Innovative Research Findings

Exploring Non-uniform Fractionation Benefits

A recent study published in *Physics in Medicine & Biology* by a collaborative team from the United States and Switzerland presents a novel strategy for estimating the maximum achievable benefits of non-uniform fractionation. Experts in physics, mathematics, and radiation oncology collaborated to create a computational tool that integrates various algorithms and mathematical principles for this measurement.

Results of the Study

The researchers tested their approach using two-dimensional slices of liver tumors, comparing it to a uniform fractionation reference. The findings indicated that non-uniform fractionation achieved equivalent target coverage while significantly reducing Biologically Effective Dose (BED), a key measure of radiation exposure, without compromising other clinical objectives. Their results demonstrated a potential reduction of BED and physical radiation dose by an average of 20%. This computational method could assist clinicians in formulating optimal treatment plans that effectively combat tumors while minimizing radiation exposure to healthy tissue.

Addressing Uncertainties in Treatment

The authors acknowledged uncertainties in their findings, such as the impact of minor patient movements between treatment fractions and soft tissue deformation. They intend to incorporate these variables into future methodologies aimed at mitigating uncertainty effects. Overall, this research offers valuable insights into the intricate mathematical framework that underlies the physical optimization of radiation treatment.

Written by Adriano Vissa, PhD
Reference: Gaddy MR et al. (2018) Optimization of spatiotemporally fractioned radiotherapy treatments with bounds of the achievable benefit. *Physics in Medicine & Biology*. 63:015036